Yuan Ziyu, Chen Liji, Ng Chong Shan, Zhuang Peishan, Huang Chongyang, Wang Jun, He Yao, Zhang Beiping, Zhong Cailing, Zhang Haiyan
The Second Clinical Medical College, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China.
Clinical College of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, China.
BMC Public Health. 2025 Sep 24;25(1):3087. doi: 10.1186/s12889-025-24105-0.
Inflammatory bowel disease (IBD) is a chronic nonspecific intestinal disorder with peak onset ages in adolescents and young adults (AYA, aged 15-39) and a lifelong risk of recurrence. AYA constitute a significant and unique proportion of its disease burden, facing challenges in fertility preservation, psychosocial support, and economic impact. Accurate epidemiological insights are crucial for national disease control and prevention strategies, yet research on AYA IBD remains sparse. This study aims to assess the burden of AYA IBD from 1990 to 2021 by global, regional, national, socio-demographic index (SDI), sex and age group, and to predict the disease burden in 2040.
Using data from the Global Burden of Disease (GBD) study, we conducted a comprehensive analysis of disability-adjusted life years (DALYs), deaths, incidence, and prevalence of AYA IBD from 1990 to 2021, with subgroup analyses by region, country, SDI, sex and age group. We calculated the estimated annual percentage changes (EAPCs) of age-standardized rates (ASRs) to assess global trends in AYA IBD burden from 1990 to 2021. We also examined the correlations between EAPC and ASR as well as SDI across countries and projected the disease burden to 2040 with Bayesian age-period-cohort (BAPC) model.
Globally, AYA IBD DALYs increased from 246,873.18 in 1990 to 320,607.21 in 2021. By 2040, DALYs are projected to continue rising steadily. East Asia saw the most marked increases in age-standardized incidence rate (ASIR) and age-standardized prevalence rate (ASPR), at 3.28% and 2.60%, respectively. Australia experienced the steepest rises in age-standardized DALYs rate (ASDR) and mortality rate (ASMR), at 1.19% and 2.33%, respectively. High SDI countries still had the highest ASDR (21.90/100,000), ASIR (13.65/100,000), and ASPR (109.31/100,000) in 2021. Middle SDI countries exhibited the largest ASDR, ASIR and ASPR increases. In 2021, the EAPCs of ASDR and ASMR were negatively correlated with SDI. Females had higher ASDR, ASMR and ASPR. The highest disease burden was observed in the 35-39 age group.
AYA IBD represents a significant global public health burden, expected to persist through 2040. With the increasing aging population, policymakers should develop appropriate strategies to mitigate the burden of AYA IBD.
炎症性肠病(IBD)是一种慢性非特异性肠道疾病,发病高峰年龄在青少年和青年(AYA,15 - 39岁),且有终生复发风险。AYA在其疾病负担中占相当大且独特的比例,在生育力保存、心理社会支持和经济影响方面面临挑战。准确的流行病学见解对于国家疾病控制和预防策略至关重要,但关于AYA IBD的研究仍然稀少。本研究旨在按全球、区域、国家、社会人口指数(SDI)、性别和年龄组评估1990年至2021年AYA IBD的负担,并预测2040年的疾病负担。
利用全球疾病负担(GBD)研究的数据,我们对1990年至2021年AYA IBD的伤残调整生命年(DALYs)、死亡、发病率和患病率进行了全面分析,并按区域、国家、SDI、性别和年龄组进行了亚组分析。我们计算了年龄标准化率(ASRs)的估计年百分比变化(EAPCs),以评估1990年至2021年AYA IBD负担的全球趋势。我们还研究了各国EAPC与ASR以及SDI之间的相关性,并使用贝叶斯年龄 - 时期 - 队列(BAPC)模型预测了2040年的疾病负担。
全球范围内,AYA IBD的DALYs从1990年的246,873.18增加到2021年的320,607.21。到2040年,预计DALYs将继续稳步上升。东亚的年龄标准化发病率(ASIR)和年龄标准化患病率(ASPR)增长最为显著,分别为3.28%和2.60%。澳大利亚的年龄标准化DALYs率(ASDR)和死亡率(ASMR)上升最为陡峭,分别为1.19%和2.33%。高SDI国家在2021年仍具有最高的ASDR(21.90/10万)、ASIR(13.65/10万)和ASPR(109.31/10万)。中等SDI国家的ASDR、ASIR和ASPR增长幅度最大。2021年,ASDR和ASMR的EAPCs与SDI呈负相关。女性的ASDR、ASMR和ASPR更高。35 - 39岁年龄组的疾病负担最高。
AYA IBD是一项重大的全球公共卫生负担,预计到2040年仍将持续。随着人口老龄化加剧,政策制定者应制定适当策略以减轻AYA IBD的负担。